Clorox Company (CLX) reported $6.76B of revenue for the twelve months ended Mar 31, 2026. That is down 3.7% from the year before. Revenue for fiscal 2025 was $7.10B.

Yes. Clorox Company earned $756.00M in net income for the twelve months ended Mar 31, 2026, a net margin of 11.2%.

How much cash and debt does CLX have?

Clorox Company reported $184.00M in cash and cash equivalents and $3.98B of debt on its most recent balance sheet in SEC filings.

How fast is CLX revenue growing?

Clorox Company's revenue changed +0.2% in fiscal 2025, to $7.10B. Its compound annual growth rate was +1.1% over 5 years and +2.3% over 10 years.

What is CLX gross margin?

Clorox Company's gross profit was $2.96B on $6.76B of revenue for the twelve months ended Mar 31, 2026, a gross margin of 43.8%.

What is CLX free cash flow?

Clorox Company generated $380.00M of free cash flow for the twelve months ended Mar 31, 2026, which is operating cash flow of $576.00M less capital expenditures.

What is CLX earnings per share?

Diluted earnings per share were $6.16 for the twelve months ended Mar 31, 2026, from SEC filings, restated for any stock split those filings show.

When did CLX last report financial results?

The latest statements here come from Clorox Company's 10-Q filed on Nov 2, 2026, covering the period ended Sep 30, 2026.

Where does this CLX financial data come from?

Quantisnow builds these statements from the structured XBRL data Clorox Company files with the SEC. It is provided for information only and is not investment advice.

Financials · CLX

Clorox Company (CLX) financials

For the twelve months ended Mar 31, 2026, Clorox Company reported $6.76B of revenue and $756.00M of net income.

Revenue, TTM: $6.76B
Revenue growth, YoY: -3.7%
Net income, TTM: $756.00M
Net margin: 11.2%
Free cash flow, TTM: $380.00M
EPS, diluted, TTM: $6.16
Cash: $184.00M
Total debt: $3.98B
P/E: 16.02
P/S: 1.79
Market cap: $12.11B

Annual revenue$7.10B

FY2016FY2025

Annual net income$810.00M

FY2016FY2025

Annual free cash flow$761.00M

FY2016FY2025

CLX revenue and earnings growth

CLX revenueQ1 2027$1.91B

Quarter YoY: +33.3%
FY YoY: +0.2%
5Y CAGR: +1.1%
10Y CAGR: +2.3%

CLX revenue was $1.91B in fiscal Q1 2027 (ended Sep 30, 2026), up 33.3% from a year earlier. For the full fiscal 2025 it was $7.10B, up 0.2% from fiscal 2024. Compound annual growth was +1.1% over 5 years and +2.3% over 10 years. It rose in 8 of the last 10 fiscal years.

CLX net incomeQ1 2027$170.00M

Quarter YoY: +112.5%
FY YoY: +189.3%
5Y CAGR: -2.9%
10Y CAGR: +3.4%

CLX net income was $170.00M in fiscal Q1 2027 (ended Sep 30, 2026), up 112.5% from a year earlier. For the full fiscal 2025 it was $810.00M, up 189.3% from fiscal 2024. Compound annual growth was -2.9% over 5 years and +3.4% over 10 years. It rose in 6 of the last 10 fiscal years.

CLX EPSQ1 2027$1.39

Quarter YoY: +113.8%
FY YoY: +189.8%
5Y CAGR: -2.4%
10Y CAGR: +3.6%

CLX diluted EPS was $1.39 in fiscal Q1 2027 (ended Sep 30, 2026), up 113.8% from a year earlier. For the full fiscal 2025 it was $6.52, up 189.8% from fiscal 2024. Compound annual growth was -2.4% over 5 years and +3.6% over 10 years.

CLX free cash flowQ1 2027$105.00M

Quarter YoY: +84.2%
FY YoY: +57.6%
5Y CAGR: -10.0%
10Y CAGR: +0.2%

CLX free cash flow was $105.00M in fiscal Q1 2027 (ended Sep 30, 2026), up 84.2% from a year earlier. For the full fiscal 2025 it was $761.00M, up 57.6% from fiscal 2024. Compound annual growth was -10.0% over 5 years and +0.2% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017	FY2016 Jun 30, 2016
Revenue	$7.10B	$7.09B	$7.39B	$7.11B	$7.34B	$6.72B	$6.21B	$6.12B	$5.97B	$5.76B
Cost of revenue	$3.89B	$4.04B	$4.48B	$4.56B	$4.14B	$3.66B	$3.49B	$3.45B	$3.30B	$3.16B
Gross profit	$3.21B	$3.05B	$2.91B	$2.54B	$3.20B	$3.06B	$2.73B	$2.67B	$2.67B	$2.60B
Research and development	$121.00M	$126.00M	$138.00M	$132.00M	$149.00M	$145.00M	$136.00M	$132.00M	$135.00M	$141.00M
Selling, general and admin	$1.12B	$1.17B	$1.18B	$954.00M	$1.00B	$969.00M	$856.00M	$837.00M	$810.00M	$806.00M
Interest expense	$88.00M	$90.00M	$90.00M	$106.00M	$99.00M	$99.00M	$97.00M	$85.00M	$88.00M	$88.00M
Pre-tax income	$1.08B	$398.00M	$238.00M	$607.00M	$900.00M	$1.19B	$1.02B	$1.05B	$1.03B	$983.00M
Income tax	$254.00M	$106.00M	$77.00M	$136.00M	$181.00M	$246.00M	$204.00M	$231.00M	$330.00M	$335.00M
Net income	$810.00M	$280.00M	$149.00M	$462.00M	$710.00M	$939.00M	$820.00M	$823.00M	$701.00M	$648.00M
EPS, basic	$6.56	$2.26	$1.21	$3.75	$5.66	$7.46	$6.42	$6.37	$5.45	$5.01
EPS, diluted	$6.52	$2.25	$1.20	$3.73	$5.58	$7.36	$6.32	$6.26	$5.35	$4.92
Diluted shares	124.3M	124.8M	124.2M	123.9M	127.3M	127.7M	129.8M	131.6M	131.6M	131.7M

Balance sheet

Balance sheet
Line item	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017	FY2016 Jun 30, 2016
Cash and equivalents	$170.00M	$207.00M	$368.00M	$186.00M	$324.00M	$879.00M	$113.00M	$134.00M	$419.00M	$405.00M
Receivables	$821.00M	$695.00M	$688.00M	$681.00M	$604.00M	$648.00M	$631.00M	$600.00M	$565.00M	$569.00M
Inventory	$523.00M	$637.00M	$696.00M	$755.00M	$752.00M	$454.00M	$512.00M	$506.00M	$459.00M	$443.00M
Current assets	$1.61B	$1.62B	$1.83B	$1.73B	$1.83B	$2.02B	$1.30B	$1.31B	$1.51B	$1.49B
Goodwill	$1.23B	$1.23B	$1.25B	$1.56B	$1.57B	$1.58B	$1.59B	$1.60B	$1.20B	$1.20B
Total assets	$5.56B	$5.75B	$5.95B	$6.16B	$6.33B	$6.21B	$5.12B	$5.06B	$4.57B	$4.51B
Current liabilities	$1.92B	$1.57B	$1.92B	$1.78B	$2.06B	$1.42B	$1.44B	$1.20B	$1.81B	$1.56B
Short-term debt	$0	$0	$0	$0	$300.00M	$0	$0	$0	$400.00M	$0
Long-term debt	$2.48B	$2.48B	$2.48B	$2.47B	$2.48B	$2.78B	$2.29B	$2.28B	$1.39B	$1.79B
Total debt	$2.48B	$2.48B	$2.48B	$2.47B	$2.78B	$2.78B	$2.29B	$2.28B	$1.79B	$1.79B
Total liabilities	$5.08B	$5.26B	$5.56B	$5.43B	$5.74B	$5.30B	$4.56B	$4.33B	$4.03B	$4.21B
Shareholders' equity	$482.00M	$492.00M	$388.00M	$729.00M	$592.00M	$908.00M	$559.00M	$726.00M	$542.00M	$297.00M

Cash flow

Cash flow
Line item	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017	FY2016 Jun 30, 2016
Operating cash flow	$981.00M	$695.00M	$1.16B	$786.00M	$1.28B	$1.55B	$992.00M	$976.00M	$865.00M	$778.00M
Capital expenditures	$220.00M	$212.00M	$228.00M	$251.00M	$331.00M	$254.00M	$206.00M	$194.00M	$231.00M	$172.00M
Free cash flow	$761.00M	$483.00M	$930.00M	$535.00M	$945.00M	$1.29B	$786.00M	$782.00M	$634.00M	$606.00M
Investing cash flow	-$94.00M	-$175.00M	-$223.00M	-$229.00M	-$452.00M	-$252.00M	-$196.00M	-$859.00M	-$205.00M	-$430.00M
Financing cash flow	-$924.00M	-$655.00M	-$753.00M	-$689.00M	-$1.39B	-$523.00M	-$815.00M	-$399.00M	-$645.00M	-$316.00M
Dividends paid	$602.00M	$595.00M	$583.00M	$571.00M	$558.00M	$533.00M	$490.00M	$450.00M	$412.00M	$398.00M
Share repurchases	$332.00M	$0	$0	$25.00M	$905.00M	$248.00M	$661.00M	$271.00M	$183.00M	$254.00M
Stock-based compensation	$81.00M	$74.00M	$73.00M	$52.00M	$50.00M	$50.00M	$43.00M	$53.00M	$51.00M	$45.00M
Depreciation and amortization	$219.00M	$235.00M	$236.00M	$224.00M	$211.00M	$180.00M	$180.00M	$166.00M	$163.00M	$165.00M

Key ratios

Key ratios
Line item	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017	FY2016 Jun 30, 2016
Revenue growth, YoY	0.2%	-4.0%	4.0%	-3.2%	9.2%	8.2%	1.5%	2.5%	3.7%	1.9%
Net income growth, YoY	189.3%	87.9%	-67.7%	-34.9%	-24.4%	14.5%	-0.4%	17.4%	8.2%	11.7%
EPS growth, YoY	189.8%	87.5%	-67.8%	-33.2%	-24.2%	16.5%	1.0%	17.0%	8.7%	7.7%
Gross margin	45.2%	43.0%	39.4%	35.8%	43.6%	45.6%	43.9%	43.7%	44.7%	45.1%
Net margin	11.4%	3.9%	2.0%	6.5%	9.7%	14.0%	13.2%	13.4%	11.7%	11.2%
Free cash flow margin	10.7%	6.8%	12.6%	7.5%	12.9%	19.2%	12.6%	12.8%	10.6%	10.5%
Return on equity	168.0%	56.9%	38.4%	63.4%	119.9%	103.4%	146.7%	113.4%	129.3%	218.2%
Return on assets	14.6%	4.9%	2.5%	7.5%	11.2%	15.1%	16.0%	16.3%	15.3%	14.4%
Current ratio	0.84	1.03	0.95	0.97	0.89	1.42	0.91	1.09	0.84	0.95
Debt to equity	5.15	5.04	6.38	3.39	4.70	3.06	4.09	3.15	3.30	6.02

Income statement

Income statement
Line item	Q1 2027 Sep 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023	Q1 2024 Sep 30, 2023
Revenue	$1.91B	$1.67B	$1.67B	$1.43B	$1.99B	$1.67B	$1.69B	$1.76B	$1.90B	$1.81B	$1.99B	$1.39B
Cost of revenue	$1.14B	$948.00M	$951.00M	$833.00M	$1.06B	$924.00M	$948.00M	$955.00M	$1.02B	$1.05B	$1.12B	$854.00M
Gross profit	$770.00M	$722.00M	$722.00M	$596.00M	$924.00M	$744.00M	$738.00M	$807.00M	$884.00M	$766.00M	$866.00M	$532.00M
Research and development	$29.00M	$27.00M	$29.00M	$28.00M	$32.00M	$27.00M	$31.00M	$31.00M	$33.00M	$32.00M	$32.00M	$29.00M
Selling, general and admin	$290.00M	$229.00M	$262.00M	$277.00M	$296.00M	$267.00M	$280.00M	$281.00M	$268.00M	$301.00M	$322.00M	$276.00M
Interest expense	$52.00M	$27.00M	$25.00M	$23.00M	$22.00M	$23.00M	$22.00M	$21.00M	$21.00M	$22.00M	$26.00M	$21.00M
Pre-tax income	$207.00M	$256.00M	$215.00M	$107.00M	$410.00M	$254.00M	$237.00M	$177.00M	$275.00M	-$42.00M	$136.00M	$29.00M
Income tax	$34.00M	$65.00M	$54.00M	$25.00M	$74.00M	$63.00M	$43.00M	$74.00M	$54.00M	$8.00M	$40.00M	$4.00M
Net income	$170.00M	$187.00M	$157.00M	$80.00M	$332.00M	$186.00M	$193.00M	$99.00M	$216.00M	-$51.00M	$93.00M	$22.00M
EPS, basic	$1.39	$1.54	$1.29	$0.65	$2.70	$1.51	$1.55	$0.80	$1.75	-$0.41	$0.75	$0.17
EPS, diluted	$1.39	$1.54	$1.29	$0.65	$2.68	$1.50	$1.54	$0.80	$1.74	-$0.41	$0.75	$0.17
Diluted shares	122.0M	121.8M	121.9M	123.0M	-	124.1M	124.7M	124.7M	-	124.2M	124.6M	124.7M

Balance sheet

Balance sheet
Line item	Q1 2027 Sep 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023	Q1 2024 Sep 30, 2023
Cash and equivalents	$184.00M	$1.19B	$227.00M	$169.00M	$170.00M	$229.00M	$294.00M	$282.00M	$207.00M	$221.00M	$358.00M	$520.00M
Receivables	$745.00M	$671.00M	$671.00M	$703.00M	$821.00M	$597.00M	$603.00M	$595.00M	$695.00M	$673.00M	$679.00M	$581.00M
Inventory	$774.00M	$588.00M	$608.00M	$577.00M	$523.00M	$635.00M	$592.00M	$594.00M	$637.00M	$674.00M	$655.00M	$710.00M
Current assets	$1.93B	$2.65B	$1.73B	$1.70B	$1.61B	$1.59B	$1.63B	$1.58B	$1.62B	$1.66B	$1.80B	$1.91B
Goodwill	$1.94B	$1.23B	$1.23B	$1.23B	$1.23B	$1.22B	$1.22B	$1.23B	$1.23B	$1.23B	$1.25B	$1.25B
Total assets	$7.83B	$6.44B	$5.61B	$5.53B	$5.56B	$5.51B	$5.58B	$5.50B	$5.75B	$5.80B	$5.91B	$5.99B
Current liabilities	$2.95B	$3.15B	$2.35B	$2.23B	$1.92B	$2.15B	$1.73B	$1.58B	$1.57B	$1.85B	$2.02B	$2.23B
Short-term debt	$1.00M	-	-	-	$0	-	-	-	$0	-	-	-
Long-term debt	$3.98B	$2.49B	$2.49B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B
Total debt	$3.98B	$2.49B	$2.49B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B	$2.48B
Total liabilities	$7.71B	$6.34B	$5.58B	$5.39B	$5.08B	$5.32B	$5.46B	$5.27B	$5.26B	$5.55B	$5.69B	$5.86B
Shareholders' equity	-$39.00M	-$67.00M	$35.00M	$138.00M	$482.00M	$190.00M	$121.00M	$224.00M	$492.00M	$255.00M	$218.00M	$131.00M

Cash flow

Cash flow
Line item	Q1 2027 Sep 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023	Q1 2024 Sep 30, 2023
Operating cash flow	$143.00M	-$122.00M	$311.00M	$93.00M	$294.00M	$286.00M	$180.00M	$221.00M	$340.00M	$182.00M	$153.00M	$20.00M
Capital expenditures	$38.00M	$43.00M	$42.00M	$36.00M	$75.00M	$53.00M	$53.00M	$39.00M	$81.00M	$55.00M	$52.00M	$24.00M
Free cash flow	$105.00M	-$165.00M	$269.00M	$57.00M	$219.00M	$233.00M	$127.00M	$182.00M	$259.00M	$127.00M	$101.00M	-$4.00M
Investing cash flow	-$35.00M	-$43.00M	-$43.00M	-$34.00M	-$76.00M	-$53.00M	-$54.00M	$89.00M	-$81.00M	-$38.00M	-$33.00M	-$23.00M
Financing cash flow	-$68.00M	$1.13B	-$210.00M	-$59.00M	-$279.00M	-$299.00M	-$109.00M	-$237.00M	-$273.00M	-$278.00M	-$259.00M	$155.00M
Dividends paid	$151.00M	$150.00M	$151.00M	$151.00M	$150.00M	$150.00M	$151.00M	$151.00M	$149.00M	$148.00M	$149.00M	$149.00M
Share repurchases	$0	$0	$127.00M	$129.00M	$75.00M	$0	$150.00M	$107.00M	$0	$0	$0	$0
Stock-based compensation	$9.00M	$15.00M	$24.00M	$10.00M	$17.00M	$24.00M	$27.00M	$13.00M	$19.00M	$26.00M	$16.00M	$13.00M
Depreciation and amortization	$74.00M	$58.00M	$55.00M	$56.00M	$57.00M	$55.00M	$53.00M	$54.00M	$59.00M	$58.00M	$57.00M	$61.00M

Key ratios

Key ratios
Line item	Q1 2027 Sep 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023	Q1 2024 Sep 30, 2023
Revenue growth, YoY	33.3%	0.1%	-0.8%	-18.9%	4.5%	-8.0%	-15.3%	27.1%	-5.7%	-5.3%	16.0%	-20.3%
Net income growth, YoY	112.5%	0.5%	-18.7%	-19.2%	53.7%	-	107.5%	350.0%	22.7%	-	-6.1%	-74.1%
EPS growth, YoY	113.8%	2.7%	-16.2%	-18.8%	54.0%	-	105.3%	370.6%	21.7%	-	-6.3%	-75.0%
Gross margin	40.4%	43.2%	43.2%	41.7%	46.5%	44.6%	43.8%	45.8%	46.5%	42.2%	43.5%	38.4%
Net margin	8.9%	11.2%	9.4%	5.6%	16.7%	11.2%	11.4%	5.6%	11.4%	-2.8%	4.7%	1.6%
Free cash flow margin	5.5%	-9.9%	16.1%	4.0%	11.0%	14.0%	7.5%	10.3%	13.6%	7.0%	5.1%	-0.3%
Current ratio	0.65	0.84	0.74	0.76	0.84	0.74	0.94	1.00	1.03	0.90	0.89	0.86
Debt to equity	-	-	71.03	18.01	5.15	13.07	20.52	11.08	5.04	9.73	11.37	18.92

Source: XBRL data Clorox Company files with the SEC, latest filing dated Nov 2, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CLX peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CLX	$6.76B	-3.7%	$756.00M	11.2%	$12.11B
CSLCarlisle Companies Incorporated	$5.21B	+4.0%	$718.40M	13.8%	$14.52B
ASHAshland Inc.	$1.84B	-1.4%	$52.00M	2.8%	$3.51B
HWKNHawkins Inc.	$1.14B	+9.0%	$85.81M	7.5%	$3.14B
NPTTexxon Holding Limited	$797.15M	+18.5%	-$932.6K	-0.1%	$41.5M
ZONEZone Frontier Inc.	$3.41M	+64.3%	-$174.16M	-5112.7%	$26.2M
YHGJYunhong Green CTI Ltd.	$19.50M	+2.8%	-$2.81M	-14.4%	$8.9M

CLX FAQ

9 questions

What is CLX revenue?
Clorox Company (CLX) reported $6.76B of revenue for the twelve months ended Mar 31, 2026. That is down 3.7% from the year before. Revenue for fiscal 2025 was $7.10B.
Is CLX profitable?
Yes. Clorox Company earned $756.00M in net income for the twelve months ended Mar 31, 2026, a net margin of 11.2%.
How much cash and debt does CLX have?
Clorox Company reported $184.00M in cash and cash equivalents and $3.98B of debt on its most recent balance sheet in SEC filings.
How fast is CLX revenue growing?
Clorox Company's revenue changed +0.2% in fiscal 2025, to $7.10B. Its compound annual growth rate was +1.1% over 5 years and +2.3% over 10 years.
What is CLX gross margin?
Clorox Company's gross profit was $2.96B on $6.76B of revenue for the twelve months ended Mar 31, 2026, a gross margin of 43.8%.
What is CLX free cash flow?
Clorox Company generated $380.00M of free cash flow for the twelve months ended Mar 31, 2026, which is operating cash flow of $576.00M less capital expenditures.
What is CLX earnings per share?
Diluted earnings per share were $6.16 for the twelve months ended Mar 31, 2026, from SEC filings, restated for any stock split those filings show.
When did CLX last report financial results?
The latest statements here come from Clorox Company's 10-Q filed on Nov 2, 2026, covering the period ended Sep 30, 2026.
Where does this CLX financial data come from?
Quantisnow builds these statements from the structured XBRL data Clorox Company files with the SEC. It is provided for information only and is not investment advice.